A Cost-Effectiveness Analysis of Voretigene Neparvovec for Vision Loss Due to Biallelic Rpe65-Mediated Inherited Retinal Disease
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1398
https://www.valueinhealthjournal.com/article/S1098-3015(18)31704-2/fulltext
Title :
A Cost-Effectiveness Analysis of Voretigene Neparvovec for Vision Loss Due to Biallelic Rpe65-Mediated Inherited Retinal Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31704-2&doi=10.1016/j.jval.2018.04.1398
First page :
Section Title :
Open access? :
No
Section Order :
644